-
Charles Hoskinson continues to unveil bold projects in healthcare and even de-extinction, but Cardano’s adoption, liquidity, and developer engagement remain far behind Ethereum and Solana.
-
Critics argue that Hoskinson’s side ventures highlight a widening gap between his promises and Cardano’s stalled progress.
Charles Hoskinson, the outspoken founder of Cardano, is known for ambitious visions that stretch far beyond blockchain. From reforming Ethiopia’s education system to building a healthcare clinic in rural Wyoming and even backing de-extinction projects, Hoskinson often pitches grand ideas.
Yet, as rivals like Ethereum and Solana race ahead in adoption and liquidity, Cardano’s reality continues to lag behind its rhetoric, drawing increasing skepticism from both developers and investors.
At the Rare Evo conference in Las Vegas in September 2025, Hoskinson once again showcased his flair for bold promises.
He unveiled a $200 million healthcare project in Gillette, Wyoming, describing it as an open-sourced, patient-first clinic already serving one-third of the local population. He claimed patients unable to pay are not charged and promised future integration of AI agents and cryptographic features.
While compelling, critics note the lack of transparent data on patient outcomes or blockchain adoption, fueling doubts about whether these initiatives are more vision than reality.
This skepticism extends to Cardano itself. Launched in 2017, Cardano did not roll out general-purpose smart contracts until 2021. When the long-awaited feature arrived, developers quickly ran into concurrency issues, exposing the rigidity of Cardano’s extended UTXO model.
The platform’s design, marketed as more secure and predictable, instead proved difficult for building complex decentralized applications. By contrast, Ethereum and Solana captured developers, users, and liquidity, leaving Cardano behind.
The numbers highlight the gap. As of September 2025, Cardano’s total value locked in DeFi sits at roughly $390 million, dwarfed by Solana’s $12.5 billion and Ethereum’s $93 billion. Ethereum processes around 1.4 million smart contract executions daily, while Cardano averages about 52,000.
Solana further widens the divide with high throughput and ultra-low fees, attracting builders that Cardano has struggled to retain.
Governance, once presented as a differentiating feature, has also proven messy. Cardano’s three-pillar structure, Input Output for protocol development, the Cardano Foundation for promotion, and Emurgo for commercial ventures, has sparked disputes over independence and influence.
A recent budget cut proposal revived tensions, while low on-chain participation showed how much decision-making remains concentrated. Despite reforms and voting mechanisms, most ADA holders either abstain or remain undelegated, limiting the effectiveness of Cardano’s governance model.
Meanwhile, Hoskinson devotes increasing attention to side ventures, including Colossal Biosciences, a company aiming to revive extinct species like the woolly mammoth and dodo. While headline-grabbing, such pursuits strike many as distractions from Cardano’s urgent need to improve adoption, liquidity, and developer momentum.
Hoskinson has long criticized Ethereum’s architecture and governance, predicting its eventual decline. But as Ethereum and Solana continue to thrive, Cardano’s slower growth and repeated delays highlight a widening gap between Hoskinson’s promises and Cardano’s actual progress.
For many in the crypto community, the question is no longer whether Cardano can deliver on Hoskinson’s vision, but whether that vision itself has shifted away from the blockchain he built.
